I am a
Home I AM A Search Login

Papers of the Week

2023 Feb 02

J Allergy Clin Immunol Pract

Lenalidomide desensitisation for delayed cutaneous reaction: A case series and review of the literature.


Ali SB, Lee W-I, Horvath N, Le T-T A, Smith W, Hissaria P
J Allergy Clin Immunol Pract. 2023 Feb 02.
PMID: 36738926.


Lenalidomide is commonly used for treatment of multiple myeloma (MM) as well as other haematological disorders. Cutaneous adverse reactions occur frequently and withholding lenalidomide treatment may have implications for prognosis.